Stem cell factor and erythropoietin inhibit apoptosis of human erythroid progenitor cells through different signalling pathways

British Journal of Haematology

Volumn 110, Issue 1, 2000, Pages 63-70

  Sui, Xingwei ^a   Krantz, Sanford B ^a,b   Zhao, Zhizhuang Joe ^a,b  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b 547 MRB II ^*  (United States)

Author keywords

Apoptosis; EPO; Human erythroid progenitors; SCF; Signal transduction

Indexed keywords

ERYTHROPOIETIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL X; PROTEIN KINASE B; STEM CELL FACTOR; WORTMANNIN;

APOPTOSIS; ARTICLE; CELL GROWTH; COLONY FORMING UNIT E; ENZYME ACTIVATION; ERYTHROCYTE LIFESPAN; ERYTHROID CELL; ERYTHROPOIESIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STEM CELL;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANDROSTADIENES; APOPTOSIS; CELLS, CULTURED; DRUG SYNERGISM; ENZYME ACTIVATION; ENZYME INHIBITORS; ERYTHROID PROGENITOR CELLS; ERYTHROPOIETIN; FLAVONOIDS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; STEM CELL FACTOR;

EID: 0033890345     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.02145.x     Document Type: Article

References (47)

1. The Bcl-2 protein family: Arbiters of cell survival
2. Death receptors: Signaling and modulation
3. The activation of p38 and apoptosis by the inhibition of Erk is antagonized by the phosphoinositide 3-kinase/Akt pathway
4. The kit receptor promotes cell survival via activation of PI 3-kinase and subsequent Akt-mediated phosphorylation of Bad on Ser136
5. Bifurcation of lipid and protein kinase signals of PI3Kγ to the protein kinases PKB and MAPK
6. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor
7. Regulation of cell death protease caspase-9 by phosphorylation
8. Fetal erythropoiesis in steel mutant mice. III. Defect in differentiation from BFU-E to CFU-E during early development
9. Polycythaemia vera. IV. Specific binding of stem cell factor to normal and polycythaemia vera highly purified erythroid progenitor cells
10. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
11. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt
12. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation
13. A matter of life and cell death
14. Overexpression of bcl-2 or bcl-XL fails to inhibit apoptosis mediated by a novel retinoid
15. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt
16. Mitochondria and apoptosis
17. The roles of Bcl-X (L) and apopain in the control of erythropoiesis by erythropoietin
18. Induction of NF-kappaB by the Akt/PKB kinase
19. Direct control of the Forkhead transcription factor AFX by protein kinase B
20. Erythropoietin
21. Apoptosis induced by withdrawal of trophic factors is mediated by p38 mitogen-activated protein kinase
22. Requirement for phosphatidylinositol 3'-kinase to protect hemopoietic progenitors against apoptosis depends upon the extracellular survival factor
23. IL-4 and insulin-like growth factor-I inhibit the decline in Bcl-2 and promote the survival of IL-3-deprived myeloid progenitors
24. Can Bad act as a key regulator of T cell apoptosis and T cell development
25. Apoptosis of human erythroid colony-forming cells is decreased by stem cell factor and insulin-like growth factor I as well as erythropoietin
26. Distinct roles of erythropoietin, insulin-like growth factor I, and stem cell factor in the development of erythroid progenitor cells
27. Expression of c-kit gene products in cellular targets of W mutations in normal and W mutant mice-evidence for an impaired c-kit kinase in mutant mice
28. Differentiation and proliferation of hematopoietic stem cells
29. NF-B, activation by tumour necrosis factor requires the Akt serine-threonine kinase
30. Cytokine rescue of p53-dependent apoptosis and cell cycle arrest is mediated by distinct Jak kinase signaling pathways
31. NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling
32. Hereditary anemias of the mouse: A review for genetics
33. Purification of human erythroid colony-forming units and demonstration of specific binding of erythropoietin
34. Quantitation of specific binding of erythropoietin to human erythroid colony-forming cells
35. Dissociation of cytokine-induced phosphorylation of Bad and activation of PKB/akt: Involvement of MEK upstream of Bad phosphorylation
36. Distinct roles of JNKs/p38 MAP kinase and ERKs in apoptosis and survival of HCD-57 cells induced by withdrawal or addition of erythropoietin
37. Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/- mice, a direct role for Stat5 in Bcl-X(L) induction
38. + cells
39. Identification of increased protein tyrosine phosphatase activity in polycythemia vera erythroid progenitor cells
40. Synergistic activation of MAP kinase (ERK1/2) by erythropoietin and stem cell factor is essential for expanded erythropoiesis
41. Caspases: Enemies within
42. Signalling through the lipid products of phosphoinositide-3-OH kinase
43. Activation of p44 and p42 MAP kinases is not essential for the survival of rat sympathetic neurons
44. Inhibition of p42 and p44 mitogen-activated protein kinase activity by PD98059 does not suppress nerve growth factor-induced survival of sympathetic neurones
45. Multiple hemopoietic growth factors stimulate activation of mitogen-activated protein kinase family members
46. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis
47. Serine phosphorylation of death agonist BAD in response to survival factor results in binding 14-3-3 not BCL-X(L)